<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14">
 <mixed-citation publication-type="book">
  <person-group person-group-type="author">
   <name>
    <surname>Elbourne</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Truong</surname>
    <given-names>V. K.</given-names>
   </name>
   <name>
    <surname>Cheeseman</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Rajapaksha</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Gangadoo</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Chapman</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2019</year>). 
  <source>
   <italic>The Use of Nanomaterials for the Mitigation of Pathogenic Biofilm Formation.</italic>
  </source>
  <edition>1st Edn</edition>
  <publisher-loc>Amsterdam</publisher-loc>: 
  <publisher-name>Elsevier Ltd</publisher-name>, 
  <pub-id pub-id-type="doi">10.1016/bs.mim.2019.04.002</pub-id>
 </mixed-citation>
</ref>
